Virica Biotech Inc.

About Virica Biotech Inc.

Virica Biotech is a cell enhancer company focused on improving manufacturing productivity and reducing costs to increase access to cell and gene therapies. They address the challenge of cellular defenses with their Viral Sensitizers (VSE™) technology, aiming to achieve higher yields, better quality, and scalability in production.

Products & Services

CellVantage™-AAV:A product focused on maximizing AAV (Adeno-Associated Virus) production for cell and gene therapies.

CellVantage™-LV:A product aimed at enhancing lentivirus manufacturing for therapeutic applications.

CellVantage™-Vaccines:A solution to increase vaccine production efficiency and scalability.

Viral Sensitizers (VSE™):A library of small molecule cell enhancers that temporarily reduce host cell defenses during production, improving viral yield and quality by up to 7x, with easy integration into existing platforms.

Specialties

Cell and Gene Therapy Manufacturing Vaccine Production Viral Sensitizers (VSE™) Technology High Throughput Virology (HTV™) Platform

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Grant T: - FT: Grant	A: 790000 MR: - FA: $790,000 FAN: 790000	D: 2023-04-21 FD: 2023-04-21	1 investors

Grant Latest

2023-04-21

$790K

1 investor (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

J

Jean-Simon Diallo

Co-Founder & Scientific Founder/CEO

LinkedIn (Pro only)

K

Ken Newport

Co-Founder & Executive Chairman

LinkedIn (Pro only)

E

Ella Korets-Smith

Co-Founder

LinkedIn (Pro only)

B

Beth Thompson-Webb

Chief Commercial Officer

A

Azra Benson

Head of Global Sales

J

JonDavid De Jong

Vice President, Scientific Operations

View 6 more team members with Pro

Unlock Full Team Directory

Recent News